CELH
Celsius Holdings, Inc.
CELH has the edge over PXED overall, supported by stronger fundamentals and stronger modeled upside.
PXED
Phoenix Education Partners, Inc
PXED has slightly lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
PXED Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Strong |
PXED's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
PXED PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.9x | $19.53 | — |
| Current | 8.5x | $19.53 | — |
| Cheap | 11x | $25.65 | +31% |
| Fair | 13x | $29.96 | +53% |
| Expensive | 19x | $42.82 | +119% |
Historical ranges are pointers, not guarantees.
PXED has the edge over CELH in the historical PE scenario, which offers more potential upside but is not a forecast.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over PXED on the outlook, with more favorable earnings and revenue expectations.
PXED Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect PXED's profitability to improve, with its earnings and revenue holding steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
PXED Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.98 | +74% |
| Q3 2026 | $2.29 | -9.1% |
| Q2 2026 | $2.18 | -34% |
| Q1 2026 | $1.62 | -49% |
| Q4 2025 | $2.64 | -17% |
| Q3 2025 | $2.52 | -31% |
PXED's earnings per share have fallen from their peak: $2.29 over the past year, against $3.64 in mid-2024.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over PXED on profitability, with a higher operating margin.
PXED Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $260.7M | +1.3% |
| Q2 2026 | $271.8M | +22% |
| Q1 2026 | $222.5M | -13% |
| Q4 2025 | $262M | +9.1% |
| Q3 2025 | $257.4M | +1.4% |
| Q2 2025 | $223.4M | +3.2% |
| Q1 2025 | $254.7M | +6.4% |
| Q4 2024 | $240.2M | +8% |
PXED's revenue is growing: $261M last quarter, up 1.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | +3.6 points |
| Q2 2026 | 19% | +7.5 points |
| Q1 2026 | 6.3% | -19 points |
| Q4 2025 | 9.8% | -4.8 points |
| Q3 2025 | 8.4% | -18 points |
| Q2 2025 | 12% | -4.7 points |
| Q1 2025 | 25% | -1.8 points |
| Q4 2024 | 15% | -3.3 points |
PXED's operating margin was 12% last quarter, up 3.6 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
PXED Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $74.2M | +151% |
| Q2 2026 | $31.8M | +32% |
| Q1 2026 | $43.5M | -15% |
| Q4 2025 | $26.4M | +$66.1M |
| Q3 2025 | $29.5M | +82% |
PXED has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over PXED on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
PXED Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -53K shares |
| 1 year | +9% | +3.2M shares |
PXED has 39M diluted shares, up 9% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.1M |
| Q3 2025 | $80.4M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
PXED Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -0.6x | Net Cash |
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q4 2024 | 0.0x | Very low |
| Q3 2024 | -1.1x | Net Cash |
PXED has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
PXED Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.4 | Oversold |
| Stochastic | 4.5 | Oversold |
PXED's weekly RSI is 28 (oversold) and its Stochastic is 5 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
PXED PE vs Consumer Defensive Sector
| Metric | PXED | Sector median | Relative |
|---|---|---|---|
| PE | 8.5x | 19x | 56% below |
| PE % | 0 | 44 | 44 pts below |
PXED has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has stronger trend alignment. CELH is above 2 of 5 weekly averages versus PXED above 0 of 3.
PXED Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.6 | 17% below |
| 20 week MA | $27.0 | 28% below |
| 50 week MA | $29.0 | 33% below |
PXED is in a downtrend: it's below all three of its weekly moving averages, and 33% below its 50-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over PXED on returns for 2026, with the stronger performance.
PXED Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $36.1 | $31.9 | -12% |
| 2026 YTD | $31.9 | $19.5 | -39% |
PXED has finished every year since 2025 lower, and it's down 39% so far in 2026.